1987
DOI: 10.1016/0014-5793(87)81060-8
|View full text |Cite
|
Sign up to set email alerts
|

Conformational changes in diphtheria toxoids

Abstract: Monoclonal antibodies (Mab) were raised against CRM197, a non-toxic mutant of diphtheria toxin (DT). The ability of four Mabs to bind DT and the six functional mutants CRM197, CRM176, CRM228, CRMlOOl, CRM45 and CRM30 was assessed by immunoblotting and by a radioimmunoassay in which the protein antigen in solution competes with labeled CRM197 for the Mab binding site. The results show that the peptides recognized by Mabl 1.3, Mab53 and Mab23 are accessible in the mutant molecules in solution but not when they a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
13
0

Year Published

1988
1988
2011
2011

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 24 publications
(16 citation statements)
references
References 31 publications
3
13
0
Order By: Relevance
“…Three distinct domains are present, the N-terminal catalytic domain (fragment A), an a-helical transmembrane domain and an all-p strand receptor-binding domain which together constitute fragment B. CRM197 contains a Gly-Glu substitution at position 52 in the catalytic domain (Giannini et al, 1984;Choe et al, 1992) which abolishes NAD binding and the ADP-ribosylation activity of the protein. It has been shown by a number of techniques that the conformation of CRM197 and diphtheria toxin differ significantly (Lory et al, 1980;Mekada and Uchida, 1985;Bigio et al, 1987). The mutation causes changes not only in the local conformation of the active site, but also in the more distant receptor-binding domain.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Three distinct domains are present, the N-terminal catalytic domain (fragment A), an a-helical transmembrane domain and an all-p strand receptor-binding domain which together constitute fragment B. CRM197 contains a Gly-Glu substitution at position 52 in the catalytic domain (Giannini et al, 1984;Choe et al, 1992) which abolishes NAD binding and the ADP-ribosylation activity of the protein. It has been shown by a number of techniques that the conformation of CRM197 and diphtheria toxin differ significantly (Lory et al, 1980;Mekada and Uchida, 1985;Bigio et al, 1987). The mutation causes changes not only in the local conformation of the active site, but also in the more distant receptor-binding domain.…”
mentioning
confidence: 99%
“…The mutation causes changes not only in the local conformation of the active site, but also in the more distant receptor-binding domain. Immunological evidence suggests that CRM197 exists in a more 'open' conformation than the native toxin at neutral pH (Bigio et al, 1987).…”
mentioning
confidence: 99%
“…Not only do the two proteins have different circular dichroism spectra (22,23) and proteolytic susceptibilities (20), but fluorescence emission measurements (20), membrane binding and insertion experiments (20,24), and antibody binding studies (25) shtow that the hydrophobic domains of CRM197 are more exposed to water than those of DTx. Moreover, the studies suggest that the structure of CRM197 at neutral pH is more similar to the structure of DTx at low pH.…”
mentioning
confidence: 99%
“…The exotoxin of toxigenic strains of C. diphtheriae is responsible for local and systemic toxicity seen during diphtheria (Mandell and Dolin, 1995). Immunity to diphtheria is mainly provided by IgG antibodyies made against the exotoxin, which is a powerful antigen (Bigio et al, 1987). Some epidemiological studies were carried out by this antigen (Holmes, 2000) and some studies were used this antigen for vaccination (Lobeck et al, 1998).…”
Section: Discussionmentioning
confidence: 99%